# Mobilization of Stem Cells With Motixafortide (BL-8040) in Combination With G-CSF in Multiple Myeloma Patients

> **NCT06514508** · PHASE3 · RECRUITING · sponsor: **Guangzhou Gloria Biosciences Co., Ltd.** · enrollment: 60 (estimated)

## Conditions studied

- Multiple Myeloma

## Interventions

- **DRUG:** Motixafortide+G-CSF
- **DRUG:** Placebo+G-CSF

## Key facts

- **NCT ID:** NCT06514508
- **Lead sponsor:** Guangzhou Gloria Biosciences Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-12-01
- **Primary completion:** 2026-12-31
- **Final completion:** 2027-05-31
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2025-12-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06514508

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06514508, "Mobilization of Stem Cells With Motixafortide (BL-8040) in Combination With G-CSF in Multiple Myeloma Patients". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06514508. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*